Article Details

Equity Research Analyst's Stock Ratings: Capricor Therapeutics, Inc. (CAPR), Nxt-ID, Inc. (NXTD)

Retrieved on: 2019-01-01 18:41:15

Tags for this article:

Click the tags to see associated articles and topics

Equity Research Analyst's Stock Ratings: Capricor Therapeutics, Inc. (CAPR), Nxt-ID, Inc. (NXTD). View article details on hiswai:

Excerpt

<div>Capricor Therapeutics, Inc. (NASDAQ:CAPR) tinted gains of +10.78% (+0.04 points) to US$0.41. The volume of 0.24 Million shares climbed down over ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo